BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24485029)

  • 21. Glomerular regeneration: when can the kidney regenerate from injury and what turns failure into success?
    Peired A; Lazzeri E; Lasagni L; Romagnani P
    Nephron Exp Nephrol; 2014; 126(2):70. PubMed ID: 24854644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
    J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.
    Kawakami T; Gomez IG; Ren S; Hudkins K; Roach A; Alpers CE; Shankland SJ; D'Agati VD; Duffield JS
    J Am Soc Nephrol; 2015 May; 26(5):1040-52. PubMed ID: 25406339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury.
    Wu L; Feng Z; Cui S; Hou K; Tang L; Zhou J; Cai G; Xie Y; Hong Q; Fu B; Chen X
    PLoS One; 2013; 8(5):e63799. PubMed ID: 23667674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy protects podocytes from sublytic complement induced injury.
    Lv Q; Yang F; Chen K; Zhang Y
    Exp Cell Res; 2016 Feb; 341(2):132-8. PubMed ID: 26883468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
    Reddy GR; Kotlyarevska K; Ransom RF; Menon RK
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagy inhibition induces podocyte apoptosis by activating the pro-apoptotic pathway of endoplasmic reticulum stress.
    Fang L; Li X; Luo Y; He W; Dai C; Yang J
    Exp Cell Res; 2014 Apr; 322(2):290-301. PubMed ID: 24424244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F577-84. PubMed ID: 16093428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutrient sensing, signaling transduction, and autophagy in podocyte injury: implications for kidney disease.
    Zha D; Wu X
    J Nephrol; 2023 Jan; 36(1):17-29. PubMed ID: 35704261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells?
    Smeets B; Dijkman HB; Wetzels JF; Steenbergen EJ
    J Pathol; 2006 Nov; 210(3):263-72. PubMed ID: 16924588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
    White KE
    Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podocytes: a new player for glutamate signaling.
    Armelloni S; Li M; Messa P; Rastaldi MP
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2272-7. PubMed ID: 23018105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine Double Minute-2 Prevents p53-Overactivation-Related Cell Death (Podoptosis) of Podocytes.
    Thomasova D; Bruns HA; Kretschmer V; Ebrahim M; Romoli S; Liapis H; Kotb AM; Endlich N; Anders HJ
    J Am Soc Nephrol; 2015 Jul; 26(7):1513-23. PubMed ID: 25349197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting signaling pathways in glomerular diseases.
    Henique C; Tharaux PL
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):417-27. PubMed ID: 22660552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Podocytes, parietal cells, and glomerular pathology: the role of cell cycle proteins.
    Nagata M; Tomari S; Kanemoto K; Usui J; Lemley KV
    Pediatr Nephrol; 2003 Jan; 18(1):3-8. PubMed ID: 12488982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases.
    Li G; Kidd J; Li PL
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagy upregulation ameliorates cell injury in Sequestosome 1 knockout podocytes in vitro.
    Li Z; Yuan Y; Meng Y; Rong Y; Bai H; Chen L
    Biochem Biophys Res Commun; 2017 Aug; 490(2):98-103. PubMed ID: 28600173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid downregulation of beta-actin-based CAG promoter and filamentous actin in injured podocytes.
    Asano T; Matsusaka T; Mizutani S; Ichikawa I
    J Med Dent Sci; 2005 Jun; 52(2):129-34. PubMed ID: 16189885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.